🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 hora
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 02/03/1989 | 0,0652 USD |
| 29/11/1988 | 0,0588 USD |
| 29/08/1988 | 0,0469 USD |
| 03/06/1988 | 0,0509 USD |
| 29/02/1988 | 0,0509 USD |
| 01/12/1987 | 0,0424 USD |
| 28/08/1987 | 0,0424 USD |
| 02/06/1987 | 0,0292 USD |
| 02/03/1987 | 0,0292 USD |
| 02/12/1986 | 0,0292 USD |
| 02/09/1986 | 0,0292 USD |
| 03/06/1986 | 0,0239 USD |
| 27/02/1986 | 0,0239 USD |
| 03/12/1985 | 0,0239 USD |
| 30/08/1985 | 0,0212 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 24/04/2003 | 54,93 | 56,13 | 54,82 | 55,63 | +0,28% | 2,38% | 6.733.714 |
| 23/04/2003 | 56,34 | 56,82 | 55,17 | 55,48 | -1,27% | 2,93% | 11.430.746 |
| 22/04/2003 | 54,82 | 56,59 | 54,74 | 56,19 | +3,39% | 3,38% | 10.347.009 |
| 21/04/2003 | 53,72 | 55,30 | 53,72 | 54,35 | +1,91% | 2,93% | 7.212.860 |
| 17/04/2003 | 53,54 | 53,82 | 52,63 | 53,33 | -0,39% | 2,21% | 6.480.413 |
| 16/04/2003 | 54,48 | 54,57 | 53,44 | 53,54 | -1,44% | 2,08% | 5.493.616 |
| 15/04/2003 | 54,06 | 54,44 | 53,77 | 54,32 | +0,46% | 1,24% | 4.734.130 |
| 14/04/2003 | 52,88 | 54,10 | 52,86 | 54,07 | +2,26% | 2,35% | 4.117.802 |
| 11/04/2003 | 53,51 | 54,05 | 52,78 | 52,88 | -0,52% | 2,37% | 4.598.729 |
| 10/04/2003 | 53,10 | 53,21 | 52,15 | 53,16 | +0,11% | 1,99% | 5.525.790 |
| 09/04/2003 | 54,11 | 54,48 | 52,96 | 53,10 | -1,87% | 2,82% | 5.401.078 |
| 08/04/2003 | 54,22 | 54,77 | 53,91 | 54,11 | -0,21% | 1,58% | 4.888.082 |
| 07/04/2003 | 55,25 | 55,77 | 54,15 | 54,23 | -0,65% | 2,94% | 5.805.920 |
| 04/04/2003 | 53,58 | 54,87 | 53,55 | 54,58 | +1,94% | 2,46% | 5.647.043 |
| 03/04/2003 | 54,17 | 54,17 | 53,39 | 53,54 | -1,16% | 1,44% | 7.892.802 |
| 02/04/2003 | 53,05 | 54,65 | 53,05 | 54,17 | +2,10% | 3,00% | 5.443.522 |
| 01/04/2003 | 52,58 | 53,24 | 52,27 | 53,05 | +1,50% | 1,85% | 5.316.399 |
| 31/03/2003 | 52,05 | 53,02 | 51,69 | 52,27 | -1,03% | 2,57% | 5.769.345 |
| 28/03/2003 | 52,55 | 53,19 | 51,99 | 52,81 | +0,51% | 2,27% | 4.441.634 |
| 27/03/2003 | 51,77 | 53,01 | 51,65 | 52,55 | +1,10% | 2,62% | 5.134.257 |
| 26/03/2003 | 52,48 | 52,83 | 51,89 | 51,98 | -1,86% | 1,80% | 6.585.632 |
| 25/03/2003 | 52,16 | 53,29 | 51,97 | 52,96 | +1,56% | 2,54% | 6.623.046 |
| 24/03/2003 | 53,66 | 53,66 | 51,77 | 52,15 | -3,27% | 3,52% | 5.978.945 |
| 21/03/2003 | 52,89 | 54,25 | 52,84 | 53,91 | +2,75% | 2,65% | 7.512.693 |
| 20/03/2003 | 51,97 | 52,56 | 51,61 | 52,47 | +0,97% | 1,82% | 6.572.742 |
| 19/03/2003 | 50,86 | 52,22 | 50,86 | 51,97 | +2,72% | 2,68% | 6.097.893 |
| 18/03/2003 | 49,83 | 50,89 | 49,81 | 50,59 | +1,57% | 2,16% | 7.021.600 |
| 17/03/2003 | 48,47 | 49,95 | 48,19 | 49,81 | +2,76% | 3,64% | 6.519.189 |
| 14/03/2003 | 48,77 | 49,52 | 48,28 | 48,47 | -0,61% | 2,54% | 6.184.458 |
| 13/03/2003 | 48,91 | 49,27 | 48,33 | 48,77 | -0,29% | 1,93% | 7.805.504 |